KYMR
Kymera Therapeutics Inc
122.10$
+3.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 28.1% | 182.5% | 3.3% | 6.4% | 240.6% | 15.7% | – | |
| – | 71.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 1,266.5% | 182.5% | 188.1% | 350.8% | 240.6% | 510.4% | 807.7% | |
| – | 272.0% | 53.6% | 49.9% | 93.6% | 70.0% | 135.0% | 174.0% | |
| – | 1,538.5% | 236.1% | 238.0% | 444.4% | 310.6% | 655.8% | 991.3% | |
| – | -1,438.5% | -136.1% | -138.0% | -344.4% | -210.6% | -555.8% | -891.3% | |
| – | 1.6% | 0.3% | 0.2% | 0.4% | 0.2% | 0.5% | 0.6% | |
| – | -1,405.8% | -134.0% | -137.6% | -330.6% | -187.0% | -475.6% | -795.0% | |
| – | 1.6% | -4.8% | -3.1% | -6.4% | 23.9% | – | – | |
| – | -1,407.4% | -134.0% | -137.6% | -330.6% | -187.0% | -475.6% | -794.4% | |
| – | -1,376.1% | -128.4% | -134.1% | -323.9% | -182.2% | -459.4% | -773.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.